Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

详细信息    查看全文

• 作者：Celia Morgan¹ ; ³ ; ^{celia.morgan@exeter.ac.uk} ; Amy McAndrew¹ ; Tobias Stevens¹ ; David Nutt² ; Will Lawn¹ ; ³
• 刊名：Current Opinion in Behavioral Sciences
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：13
• 期：Complete
• 页码：71-76
• 全文大小：244 K
• 卷排序：13

文摘

Psilocybin may reduce alcohol and tobacco use in addicted samples. Ibogaine and ayahuasca have shown promise in the treatment of various addictions through observational studies. Ketamine has been used to treat alcohol dependence and reduces cocaine self-administration in the human laboratory. Randomised controlled trials are greatly needed to further test the efficacy of all of these compounds. Psychedelic drugs may have their therapeutic qualities due to anti-depressant effects, stimulating neuroplasticity and long-term psychological changes.